Off-label Prescriptions: Do We Need More Restraint or More Evidence?
Carolyn Clancy, MD, Director of the US Agency for Healthcare Research and Quality, tells us about concerns of off-label prescriptions.
Source: MedGenMed Weekly Editorials from Medscape.com - Category: Journals (General) Authors: Carolyn Clancy, MD Source Type: podcasts